Dental Care Clinics in Mount Airy, MD Accepting Medicare
7 Dental Care Clinics found. Showing 1 - 7
 Bear Creek Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1502 S Main St Ste 101, Mount Airy, MD 21771 Phone: 301-829-7300 |
Mount Airy Dental Center Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1517 Ridgeside Dr, Mount Airy, MD 21771 Phone: 301-829-2220 |
Dr. Stuart A. Sheer Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 602 Center St, Suite 203, Mount Airy, MD 21771 Phone: 301-829-6588 Fax: 301-829-6338 |
Niraj P. Patel, Dds, Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1311 S Main St Ste 203, Mount Airy, MD 21771 Phone: 301-829-6550 Fax: 301-829-3674 |
Family Dental Center Dentist Medicare: Not Enrolled in Medicare Practice Location: 4644 Ridge Rd, Mount Airy, MD 21771 Phone: 410-875-2323 Fax: 410-875-2323 |
Damascus Dental Of Mt Airy Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1311 S Main St, Suite 203, Mount Airy, MD 21771 Phone: 301-829-6550 Fax: 301-829-3674 |
Mt. Airy Children's Dental Associates Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 602 Center St, Suite 203, Mount Airy, MD 21771 Phone: 301-829-6588 Fax: 301-829-6338 |
News Archive
Graduated driver licensing reduces fatal crashes
Graduated driver licensing programs reduce, by an average of 11 percent, the incidence of fatal crashes of 16-year-old drivers
Hepatic encephalopathy drug XIFAXAN 550 mg tablets receives FDA marketing approval
Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration has granted marketing approval for XIFAXAN 550 mg tablets for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older. HE is a serious disorder caused by chronic liver failure, resulting in cognitive, psychiatric and motor impairments. This approval was supported by findings from the largest randomized trial of maintenance therapy in HE conducted to date, which assessed the efficacy and safety of XIFAXAN 550 mg tablets and demonstrated a statistically significant and clinically meaningful reduction in the risk of overt HE recurrence.
Patient-reported experiences have potential for driving improvements in hospital care
Patient-reported experiences have potential for driving improvements in the quality of hospital care, according to a new study in the Canadian Journal of Cardiology, published by Elsevier.
Aetna sues N.J. doctors, pricing central issue
Aetna Inc. (AET) is suing six New Jersey doctors over medical bills it calls "unconscionable," including $56,980 for a bedside consultation and $59,490 for an ultrasound that typically costs $74. The
› Verified 5 days ago